COVID-19 and Thrombosis of Lower Limb Arteries

Irnazarov A.A., Yulbarisov A.A., Asrarov U.A., Matmuradov J.K.

dc.contributor.author	Irnazarov A.A., Yulbarisov A.A., Asrarov U.A., Matmuradov J.K.
dc.date.accessioned	2022-10-13T06:48:22Z
dc.date.available	2022-10-13T06:48:22Z
dc.date.issued	2022-03-26
dc.identifier.isbn	978-86-80916-01-9
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/3966
dc.description.abstract	We analyzed 72 patients with LLA thromboses from September 2020 until January 2022, which were divided into 2 groups. Main group included 38 patients, who had COVID-19 before the admission, whereas the control group included 34 covid-free patient. All patients underwent catheter thrombolysis and thromboaspiration with urokinase.	en_US
dc.language.iso	en	en_US
dc.publisher	Serbia	en_US
dc.relation.ispartofseries	УДК;616.98:578.834
dc.subject	Improve the treatment results of COVID-19 patients with thrombosis of lower limb arteries (LLA).	en_US
dc.title	COVID-19 and Thrombosis of Lower Limb Arteries	en_US
dc.type	Thesis	en_US